Spontaneous development of Alzheimer's disease‐associated brain pathology in a Shugoshin‐1 mouse cohesinopathy model

por Rao, Chinthalapally V., Farooqui, Mudassir, Zhang, Yuting, Asch, Adam S., Yamada, Hiroshi Y.
Publicado 2018

“Amyloid‐beta accumulation cycle” as a prevention and/or therapy target for Alzheimer's disease

por Rao, Chinthalapally V., Asch, Adam S., Carr, Daniel J. J., Yamada, Hiroshi Y.
Publicado 2020

Development of thrombocytopenia is associated with improved survival in patients treated with immunotherapy

por Assi, Hussein A, Asch, Adam S, Machiorlatti, Michael, Vesely, Sara K, Ibrahimi, Sami
Publicado 2020

Research Staff Perspectives on Cancer Clinical Trials and Barriers to Recruitment: A Qualitative Research

por Keruakous, Amany R, Day, Silas, Garcia-Ramiu, Kenny, Yarbrough, Melissa, Asch, Adam S
Publicado 2021

Genomic instability genes in lung and colon adenocarcinoma indicate organ specificity of transcriptomic impact on Copy Number Alterations

por Rao, Chinthalapally V., Xu, Chao, Zhang, Yuting, Asch, Adam S., Yamada, Hiroshi Y.
Publicado 2022

GSK3‐ARC/Arg3.1 and GSK3‐Wnt signaling axes trigger amyloid‐β accumulation and neuroinflammation in middle‐aged Shugoshin 1 mice

por Rao, Chinthalapally V., Farooqui, Mudassir, Madhavaram, Avanish, Zhang, Yuting, Asch, Adam S., Yamada, Hiroshi Y.
Publicado 2020

Survival-Critical Genes Associated with Copy Number Alterations in Lung Adenocarcinoma

por Rao, Chinthalapally V., Xu, Chao, Farooqui, Mudassir, Zhang, Yuting, Asch, Adam S., Yamada, Hiroshi Y.
Publicado 2021

Activation of GPR4 by Acidosis Increases Endothelial Cell Adhesion through the cAMP/Epac Pathway

por Chen, Aishe, Dong, Lixue, Leffler, Nancy R., Asch, Adam S., Witte, Owen N., Yang, Li V.
Publicado 2011

Acidosis Activation of the Proton-Sensing GPR4 Receptor Stimulates Vascular Endothelial Cell Inflammatory Responses Revealed by Transcriptome Analysis

por Dong, Lixue, Li, Zhigang, Leffler, Nancy R., Asch, Adam S., Chi, Jen-Tsan, Yang, Li V.
Publicado 2013

Caenorhabditis elegans: A Model System for Anti-Cancer Drug Discovery and Therapeutic Target Identification

por Kobet, Robert A., Pan, Xiaoping, Zhang, Baohong, Pak, Stephen C., Asch, Adam S., Lee, Myon-Hee
Publicado 2014

Seed-mediated RNA interference of androgen signaling and survival networks induces cell death in prostate cancer cells

por Corbin, Joshua M., Georgescu, Constantin, Wren, Jonathan D., Xu, Chao, Asch, Adam S., Ruiz-Echevarría, Maria J.
Publicado 2021

Androgen Signaling Promotes Translation of TMEFF2 in Prostate Cancer Cells via Phosphorylation of the α Subunit of the Translation Initiation Factor 2

por Overcash, Ryan F., Chappell, Vesna A., Green, Thomas, Geyer, Christopher B., Asch, Adam S., Ruiz-Echevarría, Maria J.
Publicado 2013

Biological effects and epidemiological consequences of arsenic exposure, and reagents that can ameliorate arsenic damage in vivo

por Rao, Chinthalapally V., Pal, Sanya, Mohammed, Altaf, Farooqui, Mudassir, Doescher, Mark P., Asch, Adam S., Yamada, Hiroshi Y.
Publicado 2017

An unbiased seed-based RNAi selection screen identifies small RNAs that inhibit androgen signaling and prostate cancer cell growth

por Corbin, Joshua M., Georgescu, Constantin, Wang, Lin, Wren, Jonathan D., Bieniasz, Magdalena, Xu, Chao, Asch, Adam S., Ruiz Echevarría, Maria J.
Publicado 2023

P699: MAGROLIMAB ALTERS THE TUMOR MICROENVIRONMENT TO IMPROVE BONE MARROW FUNCTIONS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) AND HIGHER-RISK MYELODYSPLASTIC SYNDROMES (HR-MDS)

por Johnson, Lisa, Zhang, Yajia, Su-Feher, Linda, Lee, Yeonju, A. Sallman, David, S. Asch, Adam, M. Al Malki, Monzr, Ryan Kim, Hyunjae
Publicado 2023

A TMEFF2-regulated cell cycle derived gene signature is prognostic of recurrence risk in prostate cancer

por Georgescu, Constantin, Corbin, Joshua M., Thibivilliers, Sandra, Webb, Zachary D., Zhao, Yan D., Koster, Jan, Fung, Kar-Ming, Asch, Adam S., Wren, Jonathan D., Ruiz-Echevarría, Maria J.
Publicado 2019

Safety and feasibility of outpatient chimeric antigen receptor (CAR) T-cell therapy: experience from a tertiary care center

por Borogovac, Azra, Keruakous, Amany, Bycko, Michelle, Holter Chakrabarty, Jennifer, Ibrahimi, Sami, Khawandanah, Mohamad, Selby, George B., Yuen, Carrie, Schmidt, Sarah, Autry, Marcus T., Al-Juhaishi, Taha, Wieduwilt, Matthew J., Asch, Adam S.
Publicado 2022

Tolerability and Efficacy of the Anticluster of Differentiation 47 Antibody Magrolimab Combined With Azacitidine in Patients With Previously Untreated AML: Phase Ib Results

por Daver, Naval G., Vyas, Paresh, Kambhampati, Suman, Al Malki, Monzr M., Larson, Richard A., Asch, Adam S., Mannis, Gabriel, Chai-Ho, Wanxing, Tanaka, Tiffany N., Bradley, Terrence J., Jeyakumar, Deepa, Wang, Eunice S., Sweet, Kendra, Kantarjian, Hagop M., Garcia-Manero, Guillermo, Komrokji, Rami, Xing, Guan, Ramsingh, Giridharan, Renard, Camille, Zeidner, Joshua F., Sallman, David A.
Publicado 2023

The PD-1- and LAG-3-targeting bispecific molecule tebotelimab in solid tumors and hematologic cancers: a phase 1 trial

por Luke, Jason J., Patel, Manish R., Blumenschein, George R., Hamilton, Erika, Chmielowski, Bartosz, Ulahannan, Susanna V., Connolly, Roisin M., Santa-Maria, Cesar A., Wang, Jie, Bahadur, Shakeela W., Weickhardt, Andrew, Asch, Adam S., Mallesara, Girish, Clingan, Philip, Dlugosz-Danecka, Monika, Tomaszewska-Kiecana, Monika, Pylypenko, Halyna, Hamad, Nada, Kindler, Hedy L., Sumrow, Bradley J., Kaminker, Patrick, Chen, Francine Z., Zhang, Xiaoyu, Shah, Kalpana, Smith, Douglas H., De Costa, Anushka, Li, Jonathan, Li, Hua, Sun, Jichao, Moore, Paul A.
Publicado 2023